| Authors: |
Bill A; Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Rosethorne EM; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom., Kent TC; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom., Fawcett L; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom., Burchell L; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom., van Diepen MT; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom., Marelli A; Infectious Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America., Batalov S; Infectious Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America., Miraglia L; Infectious Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America., Orth AP; Infectious Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America., Renaud NA; Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Charlton SJ; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom., Gosling M; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom., Gaither LA; Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America., Groot-Kormelink PJ; Respiratory Disease Area, Novartis Institutes for Biomedical Research, Horsham, United Kingdom; Musculoskeletal Disease Area, Novartis Institutes for Biomedical Research, Basel, Switzerland. |